Vaginitis is a common problem that affects millions of women
Ten million women each year visit their healthcare providers seeking a cure for vaginitis and a third of all women will have symptoms of vaginitis at some point during their lives, most commonly during their reproductive years.1,2 Some types of vaginitis are transferred through sexual activity, while others arise because of an imbalance in the bacterial or fungal makeup of the vaginal microbiome.3 Combined, bacterial vaginosis (BV), candida vaginitis (commonly known as a yeast infection, CV), and trichomoniasis (Trichomonas vaginalis, TV) make up 90% of vaginitis cases.3
Hologic is an innovative medical technology company focused on improving women’s health, and features two assays that aid in diagnosing BV, yeast infections, and trichomoniasis. Accurate diagnosis using the Aptima vaginal panel supports better guided drug treatment, fewer recurrent doctor’s office visits, and reduced suffering in affected women. The Aptima® BV and Aptima® CV/TV assays* usher in a new era of molecular testing, offering a comprehensive and accurate diagnosis of vaginosis and vaginitis.
*Aptima® CV/TV assays is not available in Canada at this time. Please check with your sales rep. REMOVE FROM HOLOGIC.COM as it is now available in Canada
References:
1. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991;165(Part 2): 1168-76.
2. American College of Obstetricians and Gynecologists. Vaginitis. https://www.acog.org/Patients/FAQs/Vaginitis. Published August 2011. Accessed May 28, 2019.
3. Paladine HL. Vaginitis: Diagnosis and Treatment. Am Fam Physician. Am Fam Physician. 2018 Mar 1;97(5):321-329.
